American Healthcare REIT (AHR) director Hanson discloses stock sales and 1.27M OP Units

Rhea-AI Filing Summary

American Healthcare REIT, Inc. director Jeffrey T. Hanson filed a Form 4 reporting sales of company common stock and his indirect holdings. On 12/22/2025, a trust associated with him sold 35,570 shares of common stock at a weighted average price of $48.3753 per share. On 12/23/2025, the same trust sold an additional 19,208 shares at a weighted average price of $48.4012 per share, after which the trust no longer held shares.

Hanson also reports indirect holdings through several retirement and pension accounts, including IRAs, 401(k) plans, and a defined benefit pension plan. In addition, he reports 1,268,643 OP Units in American Healthcare REIT Holdings, LP held by AHI Group Holdings, LLC, which he owns and controls with two other executives. He states that he is reporting these OP Units for transparency and continues to disclaim beneficial ownership beyond his pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hanson Jeffrey T

(Last) (First) (Middle)

18191 VON KARMAN AVE

SUITE 300

(Street)

IRVINE CA 92612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								21,798	D
Common Stock	12/22/2025		S		35,570	D	$48.3753(1)	19,208	I	By Hanson Family Trust dated 06/14/2005(2)
Common Stock	12/23/2025		S		19,208	D	$48.4012(3)	0	I	By Hanson Family Trust dated 06/14/2005(2)
Common Stock								5,552	I	By April L. Hanson IRA(4)
Common Stock								2,515	I	By Crescentridge 401K Plan(5)
Common Stock								16,720	I	By Defined Benefit Pension Plan(6)
Common Stock								729	I	By Spouse's Crescentridge 401K Plan(7)
Common Stock								4,869	I	By JTH Holdings LLC DBPP(6)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
OP Units(8)	(9)							(9)	(9)	Common Stock	1,268,643		1,268,643	I	By AHI Group Holdings, LLC(10)

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $48.2950 to $48.5700, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth herein.

2. The reported shares are held directly by Jeffrey T Hanson and April L Hanson Family Trust dated 06/14/2005, and indirectly by Mr. Hanson and April L. Hanson, Trustees. April L. Hanson is the wife of the reporting person.

3. This transaction was executed in multiple trades at prices ranging from $47.9800 to $48.5496, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth herein.

4. The reported shares are owned by April L. Hanson through her investment retirement account.

5. The reported shares are owned by Mr. Hanson through his Crescentridge Inc. 401(k) plan.

6. The reported shares are held directly in a defined benefit pension plan, of which Mr. Hanson serves as Trustee.

7. The reported shares are owned by April L. Hanson through her Crescentridge Inc. 401(k) plan.

8. Represents units of limited partnership interest in American Healthcare REIT Holdings, LP, the Issuer's operating partnership (each unit, an "OP Unit").

9. The holder of the OP Units has the right to require American Healthcare REIT Holdings, LP, to redeem part or all of the OP Units for cash, based upon the value of an equivalent number of shares of the Issuer's common stock at the time of the redemption or, at the Issuer's election, shares of the Issuer's common stock on a one-for-one basis, subject to certain adjustments and the restrictions on ownership and transfer of the Issuer's stock set forth in its charter.

10. These OP Units are held directly by AHI Group Holdings, LLC, which is owned and controlled by Mr. Hanson (the reporting person), Danny Prosky (the Issuer's Chief Executive Officer, President and a director), and Mathieu B. Streiff (one of the Issuer's non-executive directors). Mr. Hanson disclaims beneficial ownership over these OP Units, except to the extent of his pecuniary interest therein.

Remarks:

Mr. Hanson has determined to report the OP Units held directly by AHI Group Holdings, LLC, on his Section 16 reports for transparency and consistency with other public disclosures. Mr. Hanson continues to disclaim beneficial ownership over the reported OP Units.

	/s/ JEFFREY T. HANSON	12/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did AHR director Jeffrey T. Hanson report?

Jeffrey T. Hanson, a director of American Healthcare REIT, Inc. (AHR), reported sales of the company’s common stock and disclosed his indirect holdings in various accounts and OP Units.

How many AHR shares were sold in the reported Form 4 transactions?

The filing shows that a family trust associated with Jeffrey T. Hanson sold 35,570 shares of American Healthcare REIT common stock on 12/22/2025 and 19,208 shares on 12/23/2025.

At what prices were the American Healthcare REIT (AHR) shares sold?

On 12/22/2025, shares were sold at a weighted average price of $48.3753 per share, based on trades between $48.2950 and $48.5700. On 12/23/2025, shares were sold at a weighted average price of $48.4012, based on trades between $47.9800 and $48.5496.

What indirect AHR share holdings does Jeffrey T. Hanson report after these sales?

After the reported sales, Jeffrey T. Hanson reports indirect ownership of American Healthcare REIT common stock through several vehicles, including an IRA for April L. Hanson, a Crescentridge 401(k) plan, a defined benefit pension plan, his spouse’s Crescentridge 401(k) plan, and a JTH Holdings LLC defined benefit pension plan, each holding specific share amounts listed in the filing.

What are the 1,268,643 OP Units related to American Healthcare REIT (AHR)?

The Form 4 reports 1,268,643 OP Units, which are units of limited partnership interest in American Healthcare REIT Holdings, LP. The holder may require redemption of these OP Units for cash based on the value of an equivalent number of AHR common shares or, at the issuer’s election, for shares of AHR common stock on a one-for-one basis, subject to adjustments and charter restrictions.

Who holds the OP Units connected to AHR and how is Hanson involved?

The 1,268,643 OP Units are held by AHI Group Holdings, LLC, which is owned and controlled by Jeffrey T. Hanson, Danny Prosky, and Mathieu B. Streiff. Hanson reports these OP Units on his form for transparency but disclaims beneficial ownership except to the extent of his pecuniary interest.

Does the Form 4 state how the sale prices for AHR shares were calculated?

Yes. The filing explains that the reported per-share prices are weighted average sale prices from multiple trades within stated price ranges, and Hanson undertakes to provide full trade details upon request to regulators, the issuer, or its security holders.